Amer Zeidan, Professor of Medicine, Chief of Hematologic Malignancies, Director of Heme Clinical Research at Yale University, shared a post on LinkedIn:
“Outstanding contribution led by Dr. Ivan Civettini and the Humanitas University team published in NEJM Evidence which we at Yale University Yale School of Medicine were happy to be a part of it!”
Title: Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution
Authors: Ivan Civettini, Federica Malighetti, Matteo Villa, Valentina Crippa, Andrea Aroldi, Fabrizio Cavalca, Alex Graudenzi, Luca Lanino, Giulia Maggioni, Torsten Haferlach, Pierre Fenaux, Uwe Platzbecker, María Díez-Campelo, Lorenza Maria Borin, Monica Fumagalli, Arianna Zappaterra, Beatrice Manghisi, Najla H. Al Ali, David A. Sallman, Eric Padron, Zhuoer Xie, Onyee Chan, Amer M. Zeidan, Luca Mologni, Rocco Piazza, Rami S. Komrokji, Matteo Giovanni Della Porta, Carlo Gambacorti-Passerini, Daniele Ramazzotti
Other articles featuring Amer Zeidan on OncoDaily.